These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3879187)

  • 21. Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X.
    Mathur A; Zhong D; Sabharwal AK; Smith KJ; Bajaj SP
    J Biol Chem; 1997 Sep; 272(37):23418-26. PubMed ID: 9287357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-affinity, specific factor IXa binding to platelets is mediated in part by residues 3-11.
    Ahmad SS; Rawala-Sheikh R; Cheung WF; Jameson BA; Stafford DW; Walsh PN
    Biochemistry; 1994 Oct; 33(40):12048-55. PubMed ID: 7918424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
    van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
    Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. gamma-Carboxyglutamic acid (Gla)-domainless blood coagulation factor IXa species: preparation and properties.
    Morita T; Fukudome K; Miyata T; Iwanaga S
    J Biochem; 1991 Dec; 110(6):990-6. PubMed ID: 1794990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The kinetic assembly of the intrinsic bovine factor X activation system.
    Beals JM; Chibber BA; Castellino FJ
    Arch Biochem Biophys; 1989 Feb; 268(2):485-501. PubMed ID: 2492418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium binding to a human factor IXa derivative lacking gamma-carboxyglutamic acid: evidence for two high-affinity sites that do not involve beta-hydroxyaspartic acid.
    Morita T; Kisiel W
    Biochem Biophys Res Commun; 1985 Jul; 130(2):841-7. PubMed ID: 3875344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.
    Panteleev MA; Saenko EL; Ananyeva NM; Ataullakhanov FI
    Biochem J; 2004 Aug; 381(Pt 3):779-94. PubMed ID: 15104540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of residues Asn89, Ile90, and Val107 of the factor IXa second epidermal growth factor domain that are essential for the assembly of the factor X-activating complex on activated platelets.
    Yang X; Chang YJ; Lin SW; Walsh PN
    J Biol Chem; 2004 Nov; 279(45):46400-5. PubMed ID: 15328360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.
    Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K
    J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
    McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
    Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domain.
    McCord DM; Monroe DM; Smith KJ; Roberts HR
    J Biol Chem; 1990 Jun; 265(18):10250-4. PubMed ID: 2355000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIa.
    Larson PJ; Stanfield-Oakley SA; VanDusen WJ; Kasper CK; Smith KJ; Monroe DM; High KA
    J Biol Chem; 1996 Feb; 271(7):3869-76. PubMed ID: 8632006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic comparison of bovine blood coagulation factors IXa alpha and IXa beta toward bovine factor X.
    Link RP; Castellino FJ
    Biochemistry; 1983 Aug; 22(17):4033-41. PubMed ID: 6412750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of normal and abnormal human factor IX with trypsin.
    Monroe DM; Noyes CM; Straight DL; Roberts HR; Griffith MJ
    Arch Biochem Biophys; 1985 May; 238(2):490-6. PubMed ID: 3873217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural determinants of the factor IX molecule mediating interaction with the endothelial cell binding site are distinct from those involved in phospholipid binding.
    Ryan J; Wolitzky B; Heimer E; Lambrose T; Felix A; Tam JP; Huang LH; Nawroth P; Wilner G; Kisiel W
    J Biol Chem; 1989 Dec; 264(34):20283-7. PubMed ID: 2555350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of phospholipid and factor VIIIa in the activation of bovine factor X.
    van Dieijen G; Tans G; Rosing J; Hemker HC
    J Biol Chem; 1981 Apr; 256(7):3433-42. PubMed ID: 6782101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function.
    Gillis S; Furie BC; Furie B; Patel H; Huberty MC; Switzer M; Foster WB; Scoble HA; Bond MD
    Protein Sci; 1997 Jan; 6(1):185-96. PubMed ID: 9007991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme.
    Lenting PJ; ter Maat H; Clijsters PP; Donath MJ; van Mourik JA; Mertens K
    J Biol Chem; 1995 Jun; 270(25):14884-90. PubMed ID: 7797466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a factor IX variant with a glycine207 to glutamic acid mutation.
    Lin SW; Lin CN; Hamaguchi N; Smith KJ; Shen MC
    Blood; 1994 Sep; 84(6):1866-73. PubMed ID: 7915915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.